We demonstrated that ATP5A1 knockdown resulted in reduced ATP production and impaired mTOR phosphorylation in osteosarcoma cells, whereas ATP supplementation partially restored mTOR signaling. This evidence concerns the gene ATP5F1A and osteosarcoma.